Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Opioid Reduction After TKA
NCT03271151Phase 4Completed
- Sponsor
- Hospital for Special Surgery
- Start
- Sep 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Duloxetine with Placebo (2 arms). Primary endpoints: Opioid Use and Pain Scores. Started Sep 2017; status: completed.
02
Drugs
duloxetine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03271151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03271151.